Showing results (141-150 of 163) with videos related to
Sort By:
Pageof 17
Blood|September 2, 2009
Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injuryThomas V Adamkiewicz, Miguel R Abboud, Carole Paley, et al.Environmental Science & Technology|December 3, 2019
Transformation of Chlorofluorocarbons Investigated via Stable Carbon Compound-Specific Isotope AnalysisElizabeth Phillips, Tetyana Gilevska, Axel Horst, et al.Frontiers in Medicine|March 6, 2023
Clinical outcomes of children and adolescents with sickle cell disease and COVID-19 infection: A year in review at a metropolitan tertiary pediatric hospitalOlufunke Y Martin, Deepika S Darbari, Stefanie Margulies, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 30, 2021
Lentiviral vector ALS20 yields high hemoglobin levels with low genomic integrations for treatment of beta-globinopathiesLaura Breda, Valentina Ghiaccio, Naoto Tanaka, et al.Blood Advances|August 27, 2025
Improvements in Health-Related Quality of Life in Patients with Transfusion-Dependent β-Thalassemia After Exagamglogene AutotemcelJosu de la Fuente, Haydar Frangoul, Peter Lang, et al.The New England Journal of Medicine|December 10, 2021
Betibeglogene Autotemcel Gene Therapy for Non-β0/β0 Genotype β-ThalassemiaFranco Locatelli, Alexis A Thompson, Janet L Kwiatkowski, et al.Blood|January 12, 2026
Long-term efficacy and safety results of betibeglogene autotemcel gene therapy for transfusion-dependent β-thalassemiaJanet L Kwiatkowski, Alexis A Thompson, Jennifer Schneiderman, et al.Blood|January 17, 2004
Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletionsGerard Lozanski, Nyla A Heerema, Ian W Flinn, et al.American Journal of Hematology|June 8, 2026
Correction of Ineffective Erythropoiesis and Normalization of Iron Homeostasis After Exagamglogene Autotemcel in Transfusion-Dependent β-ThalassemiaSujit Sheth, Selim Corbacioglu, Josu de la Fuente, et al.The New England Journal of Medicine|April 24, 2024
Exagamglogene Autotemcel for Transfusion-Dependent β-ThalassemiaFranco Locatelli, Peter Lang, Donna Wall, et al.Pageof 17